CASE STUDY DEMOCEDES PHARMA ALGERIA was established in 2016 with the mission of addressing the growing demand for oncology treatments while ensuring continuity of supply and maintaining pharmaceutical quality at every stage of production. Following the receipt of site operation authorisation in March 2022, the company started pilot batch manufacturing, culminating in the successful completion … Lire la suite de DEMOCEDES PHARMA & IMA Active: ensuring safety, quality and compliancein highly potent drug manufacturing